BMJ Best Practice

参考文献

关键文献

Ankarklev J, Jerlström-Hultqvist J, Ringqvist E, et al. Behind the smile: cell biology and disease mechanisms of Giardia species. Nat Rev Microbiol. 2010 Jun;8(6):413-22.

Escobedo AA, Almirall P, Robertson LJ, et al. Giardiasis: the ever-present threat of a neglected disease. Infect Disord Drug Targets. 2010 Oct;10(5):329-48.

Ali SA, Hill DR. Giardia intestinalis. Curr Opin Infect Dis. 2003 Oct;16(5):453-60.

Lalle M. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives. Infect Disord Drug Targets. 2010 Aug;10(4):283-94.

Lopez-Velez R, Batlle C, Jiménez C, et al. Short course combination therapy for giardiasis after nitroimidazole failure. Am J Trop Med Hyg. 2010 Jul;83(1):171-3.

参考文章

1.  Ankarklev J, Jerlström-Hultqvist J, Ringqvist E, et al. Behind the smile: cell biology and disease mechanisms of Giardia species. Nat Rev Microbiol. 2010 Jun;8(6):413-22.

2.  Escobedo AA, Almirall P, Robertson LJ, et al. Giardiasis: the ever-present threat of a neglected disease. Infect Disord Drug Targets. 2010 Oct;10(5):329-48.

3.  Rosado JL, Caamaño MC, Montoya YA, et al. Interaction of zinc or vitamin A supplementation and specific parasite infections on Mexican infants' growth: a randomized clinical trial. Eur J Clin Nutr. 2009 Oct;63(10):1176-84.

4.  Hill DR. Giardiasis. Issues in diagnosis and management. Infect Dis Clin North Am. 1993 Sep;7(3):503-25.

5.  Chenu P, Gottrand F, Turck D, et al. Intestinal disaccharidase activity in giardiasis. J Pediatr Gastroenterol Nutr. 1992 Apr;14(3):356-7.

6.  Layton MA, Dziedzic K, Dawes PT. Sacroiliitis in an HLA B27-negative patient following giardiasis. Br J Rheumatol. 1998 May;37(5):581-3.

7.  Kappus KD, Lundgren RG Jr, Juranek DD, et al. Intestinal parasitism in the United States: update on a continuing problem. Am J Trop Med Hyg. 1994 Jun;50(6):705-13.

8.  Farthing MJ. The molecular pathogenesis of giardiasis. J Pediatr Gastroenterol Nutr. 1997 Jan;24(1):79-88.

9.  Ortega YR, Adam RD. Giardia: overview and update. Clin Infect Dis. 1997 Sep;25(3):545-9.

10.  Health Protection Agency. Giardia: guidance and data. May 2018 [internet publication].

11.  Painter JE, Gargano JW, Collier SA, et al; Centers for Disease Control and Prevention. Giardiasis surveillance - United States, 2011-2012. MMWR Suppl. 2015 May 1;64(3):15-25.

12.  Gilman RH, Brown KH, Visvesvara GS, et al. Epidemiology and serology of Giardia lamblia in a developing country: Bangladesh. Trans R Soc Trop Med Hyg. 1985;79(4):469-73.

13.  Read C, Walters J, Robertson ID, et al. Correlation between genotype of Giardia duodenalis and diarrhoea. Int J Parasitol. 2002 Feb;32(2):229-31.

14.  Flanagan PA. Giardia - diagnosis, clinical course and epidemiology. A review. Epidemiol Infect. 1992 Aug;109(1):1-22.

15.  Nash TE, Herrington DA, Losonsky GA, et al. Experimental human infections with Giardia lamblia. J Infect Dis. 1987 Dec;156(6):974-84.

16.  Haque R, Roy S, Kabir M, et al. Giardia assemblage A infection and diarrhea in Bangladesh. J Infect Dis. 2005 Dec 15;192(12):2171-3.

17.  Eligio-García L, Cortes-Campos A, Jiménez-Cardoso E. Genotype of Giardia intestinalis isolates from children and dogs and its relationship to host origin. Parasitol Res. 2005 Aug;97(1):1-6.

18.  Stuart JM, Orr HJ, Warburton FG, et al. Risk factors for sporadic giardiasis: a case-control study in southwestern England. Emerg Infect Dis. 2003 Feb;9(2):229-33.

19.  Mintz ED, Hudson-Wragg M, Mshar P, et al. Foodborne giardiasis in a corporate office setting. J Infect Dis. 1993 Jan;167(1):250-53.

20.  Ament ME, Rubin CE. Relation of giardiasis to abnormal intestinal structure and function in gastrointestinal immunodeficiency syndromes. Gastroenterology. 1972 Feb;62(2):216-26.

21.  Chin AC, Teoh DA, Scott KG, et al. Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase-3 dependent manner. Infect Immun. 2002 Jul;70(7):3673-80.

22.  Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev. 2001 Jul;14(3):447-75.

23.  Ali SA, Hill DR. Giardia intestinalis. Curr Opin Infect Dis. 2003 Oct;16(5):453-60.

24.  Oberhuber G, Kastner N, Stolte M. Giardiasis: a histologic analysis of 567 cases. Scand J Gastroenterol. 1997 Jan;32(1):48-51.

25.  Dagci H, Ustun S, Taner MS, et al. Protozoon infections and intestinal permeability. Acta Trop. 2002 Jan;81(1):1-5.

26.  Scott KG, Meddings JB, Kirk DR, et al. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology. 2002 Oct;123(4):1179-90.

27.  Eckmann L, Laurent F, Langford TD, et al. Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol. 2000 Feb 1;164(3):1478-87.

28.  Potoka DA, Upperman JS, Zhang XR, et al. Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro. Am J Physiol Gastrointest Liver Physiol. 2003 Nov;285(5):G861-9.

29.  Müller N, von Allmen N. Recent insights into the mucosal reactions associated with Giardia lamblia infections. Int J Parasitol. 2005 Nov;35(13):1339-47.

30.  Buret AG, Scott KG-E, Chin AC. Giardiasis: pathophysiology and pathogenesis. In: Olson BE, Olson ME, Wallis PM, eds. Giardia: the cosmopolitan parasite. New York, NY: CABI Pub; 2002:109-27.

31.  Gascón J. Epidemiology, etiology, and pathophysiology of traveler's diarrhea. Digestion. 2006;73 Suppl 1:102-8.

32.  Buret A, Hardin JA, Olson ME, et al. Pathophysiology of small intestinal malabsorption in gerbils infected with Giardia lamblia, Gastroenterology. 1992 Aug;103(2):506-13.

33.  Cevallos A, Carnaby S, James M, et al. Small intestinal injury in a neonatal rat model of giardiasis is strain dependent. Gastroenterology. 1995 Sep;109(3):766-73.

34.  Troeger H, Epple HJ, Schneider T, et al. Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum. Gut. 2007 Mar;56(3):328-35.

35.  Pérez PF, Minnaard J, Rouvet M, et al. Inhibition of Giardia intestinalis by extracellular factors from lactobacilli: an in vitro study. Appl Environ Microbiol. 2001 Nov;67(11):5037-42.

36.  Sackey ME, Weigel MM, Armijos RX. Predictors and nutritional consequences of intestinal parasitic infections in rural Ecuadorian children. J Trop Pediatr. 2003 Feb;49(1):17-23.

37.  Langford TD, Housley MP, Boes M, et al. Central importance of immunoglobulin A in host defense against Giardia spp. Infect Immun. 2002 Jan;70(1):11-18.

38.  Laupland KB, Church DL. Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infect Dis. 2005 Sep 16;5:72.

39.  Centers for Disease Control and Prevention. Parasites: Giardia: sources of infection & risk factors. July 2015 [internet publication].

40.  Ongerth JE, Johnson RL, Macdonald SC, et al. Backcountry water treatment to prevent giardiasis. Am J Public Health. 1989 Dec;79(12):1633-7.

41.  Nayak N, Ganguly NK, Walia BN, et al. Specific secretory IgA in the milk of Giardia lamblia-infected and uninfected women. J Infect Dis. 1987 Apr;155(4):724-7.

42.  Clasen TF, Bostoen K, Schmidt WP, et al. Interventions to improve disposal of human excreta for preventing diarrhoea. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007180.

43.  McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010 May 14;16(18):2202-22.

44.  Solomons NW. Giardiasis: nutritional implications. Rev Infect Dis. 1982 Jul-Aug;4(4):859-69.

45.  Gillon J. Clinical studies in adults presenting with giardiasis to a gastro-intestinal unit. Scott Med J. 1985 Apr;30(2):89-95.

46.  Welsh JD, Poley JR, Hensley J, et al. Intestinal disaccharidase and alkaline phosphatase activity in giardiasis. J Pediatr Gastroenterol Nutr. 1984;3(1):37-40.

47.  Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018 Aug;67(8):1380-99.

48.  Garcia LS, Shimizu RY. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J Clin Microbiol. 1997 Jun;35(6):1526-9.

49.  Al FD, Kuştimur S, Ozekinci T, et al. The use of enzyme linked immunosorbent assay (ELISA) and direct fluorescent antibody (DFA) methods for diagnosis of Giardia intestinalis. Turkiye Parazitol Derg. 2006;30(4):275-8.

50.  Weitzel T, Dittrich S, Möhl I, et al. Evaluation of seven commercial antigen detection tests for Giardia and Cryptosporidium in stool samples. Clin Microbiol Infect. 2006 Jul;12(7):656-9.

51.  Aziz H, Beck CE, Lux MF, Hudson MJ. A comparison study of different methods used in the detection of Giardia lamblia. Clin Lab Sci. 2001 Summer;14(3):150-54.

52.  Aldeen WE, Hale D, Robison AJ, et al. Evaluation of a commercially available ELISA assay for detection of Giardia lamblia in fecal specimens. Diagn Microbiol Infect Dis. 1995 Feb;21(2):77-9.

53.  Garcia LS, Shimizu RY, Novak S, et al. Commercial assay for detection of Gardia lamblia and Cryptosporidium parvum antigens in human fecal specimens by rapid solid-phase qualitative immunochromatography. J Clin Microbiol. 2003 Jan;41(1):209-12.

54.  Ghosh S, Debnath A, Sil A, et al. PCR detection of Giardia lamblia in stool: targeting intergenic spacer region of multicopy rRNA gene. Mol Cell Probes. 2000 Jun;14(3):181-9.

55.  Bruijnesteijn van Coppenraet LE, Wallinga JA, Ruijs GJ, et al. Parasitological diagnosis combining an internally controlled real-time PCR assay for the detection of four protozoa in stool samples with a testing algorithm for microscopy. Clin Microbiol Infect. 2009 Sep;15(9):869-74.

56.  Ministry of Health, British Columbia. Infectious diarrhea: guideline for ordering stool specimens. Mar 2009 [internet publication].

57.  Toward Optimized Practice (TOP) Working Group for Microbiology. Ordering stool test for investigation of suspected infectious diarrhea: clinical practice guideline. Mar 2014 [internet publication].

58.  Centers for Disease Control and Prevention. Rotavirus: clinical information. Aug 2016 [internet publication].

59.  Presutti RJ, Cangemi JR, Cassidy HD, et al. Celiac disease. Am Fam Physician. 2007 Dec 15;76(12):1795-802.

60.  Gilman RH, Marquis GS, Miranda E, et al. Rapid reinfection by Giardia lamblia after treatment in a hyperendemic Third World community. Lancet. 1988 Feb 13;1(8581):343-5.

61.  Ozbilgin A, Ertan P, Yereli K, et al. Giardiasis treatment in Turkish children with a single dose of ornidazole. Scand J Infect Dis. 2002;34(12):918-20.

62.  Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. 2001 Jan;14(1):114-28.

63.  Tian HF, Chen B, Wen JF. Giardiasis, drug resistance, and new target discovery. Infect Disord Drug Targets. 2010 Aug;10(4):295-302.

64.  Lalle M. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives. Infect Disord Drug Targets. 2010 Aug;10(4):283-94.

65.  F-D-C Reports, Inc. Romark Alinia adult dose "approvable"; anti-parasitic approved for children. Pink Sheet. 2002 Dec 2;64:11.

66.  Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis. 2001 Aug 1;184(3):381-4.

67.  Ortiz JJ, Ayoub A, Gargala G, et al. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru. Aliment Pharmacol Ther. 2001 Sep;15(9):1409-15.

68.  Davila-Gutierrez CE, Vasquez C, Trujillo-Hernandez B, et al. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am J Trop Med Hyg. 2002 Mar;66(3):251-4.

69.  Chan R, Chen J, York MK, et al. Evaluation of a combination rapid immunoassay for detection of Giardia and Cryptosporidium antigens. J Clin Microbiol. 2000 Jan;38(1):393-4.

70.  Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, et al. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis. PLoS Negl Trop Dis. 2010 May 11;4(5):e682.

71.  Rotblatt MD. Giardiasis and amebiasis in pregnancy. Drug Intell Clin Pharm. 1983 Mar 1;17(3):187-8.

72.  Duncombe VM, Bolin TD, Davis AE, et al. Histopathology in giardiasis: a correlation with diarrhoea. Aust N Z J Med. 1978 Aug;8(4):392-6.

73.  Garg BK. Furazolidone and metronidazole in the treatment of giardiasis. Indian J Pediatr. 1972 Aug;39(295):264-6.

74.  Meingassner JG, Heyworth PG. Intestinal and urogenital flagellates. Antibiot Chemother (1971). 1981;30:163-202.

75.  Murphy TV, Nelson JD. Five v ten days' therapy with furazolidone for giardiasis. Am J Dis Child. 1983 Mar;137(3):267-70.

76.  Gascón J, Abós R, Valls ME, et al. Mebendazole and metronidazole in giardial infections. Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):694.

77.  Lopez-Velez R, Batlle C, Jiménez C, et al. Short course combination therapy for giardiasis after nitroimidazole failure. Am J Trop Med Hyg. 2010 Jul;83(1):171-3.

78.  Cacopardo B, Patamia I, Bonaccorso V, et al. Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis [in Italian]. Clin Ter. 1995 Dec;146(12):761-7.

79.  Nash TE, Ohl CA, Thomas E, et al. Treatment of patients with refractory giardiasis. Clin Infect Dis. 2001 Jul 1;33(1):22-8.

80.  Popović OS, Milović V. Propranolol and metronidazole for the treatment of metronidazole-resistant giardiasis. J Clin Gastroenterol. 1990 Oct;12(5):604-5.

81.  Smith PD, Gillin FD, Spira WM, et al. Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response. Gastroenterology. 1982 Oct;83(4):797-803.

82.  Taylor GD, Wenman WM, Tyrrell DL. Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis. CMAJ. 1987 Jun 1;136(11):1179-80.

83.  Samuelson J. Why metronidazole is active against both bacteria and parasites. Antimicrob Agents Chemother. 1999 Jul;43(7):1533-41.

84.  Gazder AJ, Banerjee M. Single-dose treatment of giardiasis in children: a comparison of tinidazole and metronidazole. Curr Med Res Opin. 1977;5(2):164-8.

85.  Goto R, Mascie-Taylor CG, Lunn PG. Impact of anti-Giardia and anthelminthic treatment on infant growth and intestinal permeability in rural Bangladesh: a randomised double-blind controlled study. Trans R Soc Trop Med Hyg. 2009 May;103(5):520-9.

86.  Ochoa TJ, Chea-Woo E, Campos M, et al. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin Infect Dis. 2008 Jun 15;46(12):1881-3.

87.  Cañete R, Escobedo AA, González ME, et al. Randomized clinical study of five days' therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children. World J Gastroenterol. 2006 Oct 21;12(39):6366-70.

88.  Pickering LK, Woodward WE, DuPont HL, et al. Occurrence of Giardia lamblia in children in day care. J Pediatr. 1984 Apr;104(4):522-6.

89.  Farthing MJ, Mata L, Urrutia JJ, et al. Natural history of Giardia infection of infants and children in rural Guatemala and its impact on physical growth. Am J Clin Nutr. 1986 Mar;43(3):395-405.

90.  Girard C, Dereure O, Blatiere V, et al. Vitamin a deficiency phrynoderma associated with chronic giardiasis. Pediatr Dermatol. 2006 Jul-Aug;23(4):346-9.

91.  Jakubowski W. Purple burps and the filtration of drinking water supplies. Am J Public Health. 1988 Feb;78(2):123-5.

使用此内容应接受我们的免责声明